Our Mission
The mission of SLC6A1 Europe, Research & Support Alliance (SERSA) is to accelerate the development of targeted treatments, while strengthening support, knowledge, and connection for families across Europe.
We unite science and community to ensure that research advances efficiently, clinical trials are accessible to people with SLC6A1-related neurodevelopmental disorder (SLC6A1-NDD) across Europe, and families are supported at every stage of the journey.
Our Vision
We envision a future where:
-
Every individual with SLC6A1-NDD receives an early and accurate diagnosis.
-
Evidence-based SLC6A1 treatments are available and accessible across Europe.
-
Disease-modifying therapies are developed and accessible.
-
Families are supported within a connected and informed community.
-
European research efforts are coordinated and globally competitive.
-
Long-term outcomes and quality of life for patients and families affected are significantly improved.